WebApr 10, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Cytosorbents stock is Buy based on the current 1 buy rating for CTSO. The average twelve-month price prediction for Cytosorbents is $5.75 with a high price target of $6.00 and a low price target of $5.50. Learn more on CTSO's analyst rating history. WebGet the latest Cytosorbents Corp (CTSO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …
Cytosorbents (NASDAQ:CTSO) Share Price Crosses Above Two …
WebNov 3, 2024 · PRNewswire/ -- CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q2 2024 financial results after the market close on … WebApr 13, 2024 · Get the latest CytoSorbents Corporation (CTSO) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. small business renewal health canada
Cytosorbents Corporation (CTSO) Latest Stock News Seeking Alpha
WebApr 11, 2024 · Posted by Defense World Staff on Apr 11th, 2024. Shares of Cytosorbents Co. ( NASDAQ:CTSO – Get Rating) crossed above its 200-day moving average during trading on Monday . The stock has a 200 ... WebApr 11, 2024 · Beauty Health presently has a consensus price target of $19.50, indicating a potential upside of 55.63%. Cytosorbents has a consensus price target of $5.75, indicating a potential upside of 74.24% ... WebMar 22, 2024 · Cytosorbents Corp stock news, updates & related news. Find out why Cytosorbents Corp's (CTSO) news sentiment is 12.14% more negative in relation to … small business remote desktop with anti-virus